The 2023 Fall Clinical Dermatology conference featured research on treatments for alopecia areata, acne, psoriasis, atopic dermatitis, and vitiligo. The Fall Clinical Dermatology conference presented ...

The Clinical Trials on Alzheimer's Disease (CTAD) conference and the Alzheimer's Drug Discovery Foundation (ADDF) today announced they will collaborate on CTAD's annual Biotech Showcase, bringing ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on targeted cell therapies for autoimmune diseases, announced that updated clinical data on its investigational therapy, ...

The Conference Forum announced today the launch of the 9th annual CRAACO®: Clinical Research as a Care Option conference, taking place September 16, 2024 at the Loews Philadelphia Hotel in ...

Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve® data featured ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (Nasdaq: BIIB) today announced new interim Phase 2 results from NURTURE, the ongoing open-label, single-arm study evaluating the efficacy and safety of ...

The University of Health Sciences (UHS) is organising a series of clinico-pathological conferences, which will be facilitated by noted medical experts. The first conference of the series was held on ...

The increasing incidence of cancer in sub-Saharan Africa (SSA) has highlighted gaps in access to quality cancer care and subsequent poor outcomes. Two of the factors responsible for this disparity are ...

BOSTON--(BUSINESS WIRE)--Follica, Inc. [“Follica”], a biotechnology company developing a regenerative platform designed to treat androgenetic alopecia (AGA), epithelial aging and other related ...

Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials <?xml version="1.0" encoding="UTF-8"?> Abiola Ibraheem, ...

Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve® over 6-12 weeks Preclinical in vitro ...